Two pilot projects to test PDMPs

Healthcare providers and pharmacists will be able to identify and intervene in cases of potential prescription drug abuse through a new pilot program launched recently by the Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology, according to an HHS statement. » More

Continuing Education

Psychopharmacology for the elderly

Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

Humana, Novo Nordisk partner for diabetes care

Humana Inc. and Novo Nordisk have announced a one-year partnership aimed at identifying ways to improve the care and treatment of patients with diabetes. The companies say they will bring together researchers to study the treatment and progression of the disease in an effort to further enhance the health and well-being of people with diabetes. » More

Certain EDCs linked to allergy risk in kids

Urinary levels of the antimicrobial endocrine-disrupting compounds triclosan and parabens were significantly associated with allergic sensitization in children ages 6 to 18 years, according to the results of a study published online June 18 in the Journal of Allergy and Clinical Immunology. » More

NCPA is accepting award nominations

The National Community Pharmacists Association recently announced that nominations are currently being accepted for several awards that will recognize individual pharmacists who are contributing to independent community pharmacy and patient care. » More

TAKE OUR SURVEY

Do you support the repeal of the Accountable Care Act?

a) Yes
b) No

Respond here and see what your colleagues think, too.

Want to see the results of our last survey about the most important drivers of a successful retail pharmacy leader? Click here.

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

• Tracking patients' Rx drug use

• FDA rejects wider use of rivaroxaban

• ADHD students and early treatment

• Drugmakers seek EU deal for supplies

Voices

DT Blog: The simple truth of retail chain pharmacy

JP at Large: This is pharmacy?

View from the Zoo: The vertebral solution

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.